PTC Therapeutics
PTCT
63.23
-0.47
-0.74%
PTC Therapeutics
US · PTCT
#2071 by market cap
Listed 1970
63.23
-0.47
-0.74%
Live - 5344 symbols - heartbeat 399s ago
· 2026-10-07 19:54
After-hours
63.23
0.00%
- Market cap
- 5.28B
- P/E (TTM)i
- -103.66
- P/Bi
- -31.92
- EPSi
- 7.78
- Div yieldi
- 0.00%
- 52W posi
- 7%
Reader sentiment
Are you bullish or bearish on PTCT?
Anonymous reader poll. Unscientific, not investment advice.
About PTC Therapeutics
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.
- Founded
- 1998
- CEO
- Dr. Matthew B. Klein, F.A.C.S.,M.D.,M.S.
- Employees
- 1,047
- Headquarters
- Warren, New Jersey, United States of America
- Fiscal year end
- 12-31
- Website
- ptcbio.com
Company profile
- Exchange
- US
- Symbol
- PTCT
- Market-cap rank
- #2071
- Listing date
- 1970-01-01
- Market cap
- 5.28B
- Float cap
- 4.66B
- Shares out
- 83.46M
- Float shares
- 73.69M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.